A*Star enterprise arm inks deal to set up deep-tech startups

Singapore

THE enterprise arm of the Agency for Science, Technology and Research (A*Star), A*ccelerate, on Wednesday signed a US$90 million agreement with Nasdaq-listed pharmaceutical firm Aptorum Group and Hong Kong financial institution Aeneas Capital to co-create local deep-tech startups in healthcare and the life sciences.

This is the latest in a series of venture co-creation agreements that A*ccelerate has entered into. Under the agreement, Aptorum and A*ccelerate aim to establish up to 20 deep-tech ventures in Singapore over the next five years.